Abbott Laboratories
(NYSE) ABT
Abbott Laboratories Financials at a Glance
Market Cap
$168.61B
Revenue (TTM)
$45.13B
Net Income (TTM)
$6.28B
EPS (TTM)
$3.59
P/E Ratio
26.97
Dividend
$2.44
Beta (Volatility)
0.54 (Low)
Dividend
$2.44
Beta (Volatility)
0.54 (Low)
Price
$96.89
Volume
17,559,852.516
Open
$95.62
Price
$96.89
Volume
17,559,852.516
Open
$95.62
Previous Close
$96.81
Daily Range
$94.87 - $97.14
52-Week Range
$93.92 - $139.06
Dividend
$2.44
Beta (Volatility)
0.54 (Low)
Price
$96.89
Volume
17,559,852.516
Open
$95.62
Previous Close
$96.81
Daily Range
$94.87 - $97.14
52-Week Range
$93.92 - $139.06
ABT News
ABT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Abbott Laboratories
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
115,000
CEO
Robert B. Ford, MBA
Website
www.abbott.comHeadquarters
Abbott Park, IL 60064-6400, US
ABT Financials
Key Financial Metrics (TTM)
Gross Margin
56%
Operating Margin
18%
Net Income Margin
14%
Return on Equity
13%
Return on Capital
12%
Return on Assets
7%
Earnings Yield
3.71%
Dividend Yield
0.03%
Payout Ratio
65.58%
Stock Overview
Market Cap
$168.61B
Shares Outstanding
1.74B
Volume
17.56M
Short Interest
0.00%
Avg. Volume
12.40M
Financials (TTM)
Gross Profit
$24.61B
Operating Income
$8.05B
EBITDA
$11.55B
Operating Cash Flow
$9.57B
Capital Expenditure
$2.17B
Free Cash Flow
$7.39B
Cash & ST Invst.
$8.94B
Total Debt
$15.07B
Abbott Laboratories Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$11.16B
+7.8%
Gross Profit
$6.28B
+15.4%
Gross Margin
56.28%
N/A
Market Cap
$168.61B
N/A
Market Cap/Employee
$1.48M
N/A
Employees
114,000
N/A
Net Income
$1.08B
-18.7%
EBITDA
$1.84B
-31.0%
Quarterly Fundamentals
Net Cash
$6.13B
+16.1%
Accounts Receivable
$7.93B
+14.5%
Inventory
$6.49B
+4.7%
Long Term Debt
$11.76B
-13.0%
Short Term Debt
$3.31B
+88.7%
Return on Assets
7.24%
N/A
Return on Invested Capital
11.68%
N/A
Free Cash Flow
$2.63B
+22.3%
Operating Cash Flow
$3.31B
+15.6%